SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC the metals company is rapidly gaining attention following NOAA's new streamlined deep-sea mining permit framework and TMC's swift filing of a significantly expanded commercial recovery application. This immediate regulatory action, amplified by an upcoming Congressional hearing featuring TMC's CEO, has fueled strong bullish sentiment, with the community actively discussing potential short-squeeze dynamics and the company's crucial role in securing critical minerals for national security. Investors anticipate a major re-rating as regulatory risks decrease and the strategic importance of deep-sea resources gains prominence.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is a major trending topic after CEO Ryan Cohen significantly increased his personal stake, purchasing 1 million shares over two days, with another director also adding to their holdings. The community is buzzing with excitement, interpreting these insider buys as a strong vote of confidence and a potential catalyst for a renewed short squeeze, putting immense pressure on bearish positions. Many are actively discussing whether this signals a highly anticipated "round two" for the prominent meme stock.

60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.

60 Degrees Pharmaceuticals Inc

Shares of 60 Degrees Pharmaceuticals are trending following a major partnership announcement with Runway Health to expand access to their FDA-approved malaria prevention drug, ARAKODA. This immediate catalyst has ignited widespread community discussion, with many anticipating continued upside, while others caution about a potential pump-and-dump and looming dilution after recent reverse splits.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is trending following a positive analyst upgrade, including a reiterated "Buy" rating and a high price target from Jefferies, which is fueling bullish sentiment. The community is actively discussing the company's AI advancements and Threads monetization, anticipating further upside as earnings approach. Many view it as an undervalued Magnificent Seven member poised for a significant move.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ Corp is trending following a significant Memorandum of Understanding with the Gujarat Government to establish a major post-quantum semiconductor hub in India. The community is buzzing about this foundational move for next-gen chip production, seeing it as a massive catalyst driving strong buying momentum. Many anticipate a substantial upward move, with discussions around a potential short squeeze for this cutting-edge quantum security firm.

Lemonade, Inc. is a holding company, which engages in the provision of insurance services. The firm's products include renters and homeowners insurance, and pet insurance. It offers insurance coverage under the homeowners multi-peril, inland marine, and general liability lines of business. The company was founded by Daniel Asher Schreiber and Shai Wininger on June 17, 2015 and is headquartered in New York, NY.

Lemonade Inc

Lemonade is currently trending following an earnings report that exceeded expectations and news of substantial insurance rate reductions for Tesla Full Self-Driving users, which gained significant attention online. This has fueled widespread speculation about a potential short squeeze and vigorous community debate on the long-term viability and disruptive potential of its AI-driven insurtech model.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending as investors grapple with a significant stock sell-off, despite recent strong performance, driven by market apprehension over margin outlook and changes in capital allocation strategy. Community sentiment is sharply divided, with bulls viewing the current valuation as a prime buying opportunity, particularly given the strategic potential of a Warner Bros. Discovery acquisition. However, the proposed deal is also fueling bear arguments around increased debt and integration challenges, contributing to intense debate and highly volatile price action.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital (NUAI) is trending after establishing a strategic partnership with Primary Digital Infrastructure to co-develop a 1+ gigawatt hyperscale data center campus in Texas, alongside recently acquiring full ownership of Texas Critical Data Centers. The community is highly anticipating an announcement regarding a major hyperscaler tenant, fueling widespread discussion of explosive upside potential as a key player in the rapidly expanding AI data center and energy sector.

Ascent Solar Technologies, Inc. engages in the design, development, and manufacture of solar technology and power solutions for remote locations and extreme environments. It integrates photovoltaic modules into a variety of applications such as aerospace, defense, transportation, and electronic products. The company was founded by Mohan S. Misra and Joseph H. Armstrong on October 18, 2005 and is headquartered in Thornton, CO.

Ascent Solar Technologies Inc

Ascent Solar Technologies (ASTI) is trending after Elon Musk's recent comments emphasized the need for featherweight, space-integrated solar, a niche where ASTI's flexible thin-film technology is positioned. The community is actively discussing ASTI's strategic ties, including a SpaceX founding member on its board, and its involvement with major space defense initiatives. This micro-cap's low float and 

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending amid significant institutional accumulation and an analyst price target increase, fueling speculation about impending government defense contracts for its drone technology. The community is actively discussing strong revenue growth and the company's strategic positioning within the expanding U.S. drone market, with many anticipating a substantial short squeeze and a re-rating of its valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Beam Therapeutics (NASDAQ:BEAM) Insider Sells $644,749.69 in Stock

Beam Therapeutics Inc. (NASDAQ:BEAM - Get Free Report) insider Christine Bellon sold 18,629 shares of the firm's stock in a transaction on Thursday, January 15th. The stock was sold at an average...

Insider Selling: Beam Therapeutics (NASDAQ:BEAM) Insider Sells 18,629 Shares of Stock

Beam Therapeutics Inc. (NASDAQ:BEAM - Get Free Report) insider Christine Bellon sold 18,629 shares of the business's stock in a transaction that occurred on Thursday, January 15th. The shares were...

Cathie Wood sends blunt 3-word message on stock outlook in 2026

Cathie Wood is making another bold call on the U.S. economy and stock market.In a 2026 outlook letter published on Jan. 15, the ARK Invest founder and CEO says the U.S. economy is storing up energy...

SG Americas Securities LLC Purchases 36,004 Shares of Beam Therapeutics Inc. $BEAM

SG Americas Securities LLC grew its position in Beam Therapeutics Inc. (NASDAQ:BEAM - Free Report) by 498.9% during the third quarter, according to its most recent 13F filing with the SEC. The...

Beam Therapeutics (NASDAQ:BEAM) Stock Price Down 6.1% - Should You Sell?

Beam Therapeutics (NASDAQ:BEAM) Trading Down 6.1% - Should You Sell...

BEAM Outlines Key Strategic & Pipeline Goals for 2026, Stock Rises

Beam Therapeutics jumps 22% after outlining 2026 pipeline goals, including accelerated approval plans for BEAM-302 and a potential risto-cel BLA filing.

Beam Therapeutics (NASDAQ:BEAM) Reaches New 1-Year High - Still a Buy?

Beam Therapeutics (NASDAQ:BEAM) Sets New 52-Week High - Time to Buy...

Beam Therapeutics (NASDAQ:BEAM) Shares Gap Up - Time to Buy?

Beam Therapeutics (NASDAQ:BEAM) Shares Gap Up - Still a Buy...

Beam Therapeutics Stock Surges: What's Driving The Sudden Jump?

Beam Therapeutics shares are popping on Monday after the company laid out a series of pipeline updates and strategic priorities for 2026.read more...

<ul class="summary-bullets"><li>The company expects to submit a biologics license application for risto-cel by year-end 2026.</li><li>Beam ended 2025 with an estimated $1.25 billion in cash, extending its operating runway into 2029.</li><li>Management will further discuss the developments at the J.P. Morgan Healthcare Conference on January 13.</li></ul>Beam Therapeutics Inc. (BEAM) received a boost from William Blair, which reacted&nbsp;positively to the company’s update on its alignment with the U.S. FDA, citing improved visibility into the data required for regulatory submissions. The firm pointed to progress in Beam’s sickle cell therapy risto-cel and its liver-targeted program BEAM-302.William Blair also noted that both programs’ acceptance into the FDA’s Chemistry, Manufacturing, and Controls Development and Readiness Pilot program could speed development and regulatory review. The brokerage firm reiterated its ‘Outperform’ rating.<h2 class="st-heading-2">Updates on BEAM-302 and Risto-cel</h2>Beam’s update outlined progress across its genetic disease and hematology franchises. The company said it has aligned with the FDA on a potential accelerated approval pathway for BEAM-302 in alpha-1 antitrypsin deficiency (AATD), based on biomarker endpoints. BEAM-302 has shown an in vivo correction of a disease-causing mutation in AATD, and Beam Therapeutics plans to expand patient enrollment to support a future biologics license application (BLA).<a href="https://stocktwits.com/symbol/BEAM">Beam Therapeutics’ stock</a> gained over 28% On Monday afternoon.In hematology, Beam expects to submit a BLA for risto-cel by year-end 2026. The BEACON Phase 1/2 trial is fully enrolled, manufacturing is complete, and recent data continue to show strong efficacy and a predictable manufacturing profile, potentially improving patient experience and treatment center capacity, the company said.Beyond its clinical progress, Beam ended 2025 with an estimated $1.25 billion in cash, extending its operating runway into 2029. This positions the company to fund the anticipated launch of risto-cel and execute pivotal development plans for BEAM-302 without near-term financing risk.Management will further discuss these developments at the J.P. Morgan Healthcare Conference on January 13.<h2 class="st-heading-2">Retail Remains Extremely Bullish</h2>Retail sentiment on Stocktwits remained in the ‘extremely bullish’ zone over the past 24 hours, accompanied by ‘extremely high’ message volumes.<figure class="image"><img src="https://news.stocktwits-cdn.com/BEAM_jpg_e1fba90ff6.webp" alt="BEAM.jpg" width="925" height="99"><figcaption>&nbsp;</figcaption></figure>One user expects a buyout.<stembedurl>https://stocktwits.com/ReadyMate/message/641529269</stembedurl>Another user expects ‘good times’ ahead.<stembedurl>https://stocktwits.com/Millard_Findlemeyer/message/641539254</stembedurl>Over the past year, the stock has gained around 38%.Read also:<a href="https://stocktwits.com/news-articles/markets/equity/why-did-planet-labs-stock-gain-today/cmUad7cR4Ej">&nbsp;Planet Labs Stock Gained 7% Today — What Is The Swedish Military Deal About?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising chart and reflection of business buildings: stock photo courtesy of Yuichiro Chino via Getty Images

BEAM Stock In Focus As FDA Alignment Wins William Blair’s Praise 

William Blair welcomed the company’s update on its alignment with the U.S. FDA, saying it gives clear visibility into the data needed for regulatory filings.

Equity

Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.

Beam Therapeutics Inc

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

BEAM
Beam Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BEAM News

BEAMBeam Therapeutics Inc